Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer Into the Cochlea.
Title
Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer Into the Cochlea.
Creator
Liu Yuhe; Okada Takashi; Shimazaki Kuniko; Sheykholeslami Kianoush; Nomoto Tatsuya; Muramatsu Shin-Ichi; Mizukami Hiroaki; Kume Akihiro; Xiao Shuifang; Ichimura Keiichi; Ozawa Keiya
Publisher
Molecular therapy : the journal of the American Society of Gene Therapy
Date
2008
2008-03
Description
Since standard aminoglycoside treatment progressively causes hearing disturbance with hair cell degeneration, systemic use of the drugs is limited. Adeno-associated virus (AAV)-based vectors have been of great interest because they mediate stable transgene expression in a variety of postmitotic cells with minimal toxicity. In this study, we investigated the effects of regulated
Identifier
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Citation
Liu Yuhe; Okada Takashi; Shimazaki Kuniko; Sheykholeslami Kianoush; Nomoto Tatsuya; Muramatsu Shin-Ichi; Mizukami Hiroaki; Kume Akihiro; Xiao Shuifang; Ichimura Keiichi; Ozawa Keiya, “Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer Into the Cochlea.,” NEOMED Bibliography Database, accessed April 26, 2024, https://neomed.omeka.net/items/show/4002.